Completed

Randomized Study of Intensive One-on-one Behavioral Treatment Versus Individualized Parent Training in Preschool Aged Children With Autism

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

intensive one-on-one behavioral treatment

+ Individualized in home parent training

Behavioral
Who is being recruted

Autism Spectrum Disorder+9

+ Child Development Disorders, Pervasive

+ Nervous System Diseases

From 2 to 3 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: May 1998
See protocol details

Summary

Principal SponsorUniversity of California, Los Angeles
Last updated: May 27, 2015
Sourced from a government-validated database.Claim as a partner

Study start date: May 1, 1998

Actual date on which the first participant was enrolled.

PROTOCOL OUTLINE: This is a randomized study. Children are randomized to receive either 35 hours of intensive one-on-one behavioral treatment in the home and neighborhood for 2 years or individualized, in home parent training for 6 months. A common group of tests to evaluate autism are administered at intake, 12 and 24 months into treatment, and when patients reach age 6.

NCT00004449
Principal SponsorUniversity of California, Los Angeles
Last updated: May 27, 2015
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

102 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 2 to 3 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Autism Spectrum DisorderChild Development Disorders, PervasiveNervous System DiseasesPathologic ProcessesSigns and SymptomsPathological Conditions, Signs and SymptomsDisease AttributesNeurodevelopmental DisordersAutistic DisorderMental DisordersNeurologic ManifestationsRare Diseases

Criteria

INCLUSION CRITERIA: --Disease Characteristics-- Diagnosis of autism based on the Autism Diagnostic Interview using the ICD-10 research criteria Ratio IQ score greater than 35 determined from the Bayley Scales of Infant Development --Patient Characteristics-- Other: Must reside within 60 km (37.5 miles) of a treatment site EXCLUSION CRITERIA: Severe medically induced limitations defined as: Any condition requiring prosthetic devices (e.g., blindness, deafness, or cerebral palsy) Any illness that has prevented or would prevent a subject from participating in 30 hours a week of treatment for six consecutive weeks or more (e.g., metastasized cancer or end stage renal disease) Any known genetic disorder (e.g., Fragile X, PKU, or Down Syndrome) Any other disorder that rules out autism according to ICD-10 criteria (e.g., Rett's Syndrome)

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
CompletedNo study centers